Axsome Therapeutics Inc (AXSM)
74.16
-0.73
(-0.97%)
USD |
NASDAQ |
May 02, 16:00
74.17
+0.01
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics Gross Profit Margin (Quarterly): 89.69% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 89.69% |
September 30, 2023 | 88.70% |
June 30, 2023 | 90.15% |
March 31, 2023 | 92.01% |
Date | Value |
---|---|
December 31, 2022 | 90.60% |
September 30, 2022 | 88.58% |
June 30, 2022 | 88.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
88.58%
Minimum
Sep 2022
92.01%
Maximum
Mar 2023
89.80%
Average
89.69%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
Amgen Inc | 62.03% |
Vertex Pharmaceuticals Inc | 85.38% |
Krystal Biotech Inc | 93.19% |
Alnylam Pharmaceuticals Inc | 80.47% |
Catalyst Pharmaceuticals Inc | 85.70% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -124.5% |
Return on Assets | -47.44% |
Return on Invested Capital | -68.95% |
Profit Margin (Quarterly) | -137.9% |
Operating Margin (Quarterly) | -76.98% |
Return on Net Operating Assets | -162.8% |